Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.
Saved in:
| Title: | Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials. |
|---|---|
| Authors: | Kaul I; Bristol Myers Squibb, Princeton, NJ, USA., Sawchak S; Bristol Myers Squibb, Princeton, NJ, USA., Claxton A; Bristol Myers Squibb, Princeton, NJ, USA., Sauder C; Bristol Myers Squibb, Princeton, NJ, USA., Hassman HH; CenExel-Hassman Research Institute, Marlton, NJ, USA., Kakar R; Segal Trials, Lauderhill, FL, USA., Walling DP; CenExel-Collaborative Neuroscience Research, Los Alamitos, CA, USA., Citrome L; New York Medical College, Valhalla, NY, USA., Zhu H; Bristol Myers Squibb, Princeton, NJ, USA., Miller AC; Bristol Myers Squibb, Princeton, NJ, USA., Brannan SK; Bristol Myers Squibb, Princeton, NJ, USA. sbrannan@karunatx.com. |
| Source: | Schizophrenia (Heidelberg, Germany) [Schizophrenia (Heidelb)] 2025 Mar 18; Vol. 11 (1), pp. 44. Date of Electronic Publication: 2025 Mar 18. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature Limited Country of Publication: Germany NLM ID: 9918367987006676 Publication Model: Electronic Cited Medium: Internet ISSN: 2754-6993 (Electronic) Linking ISSN: 27546993 NLM ISO Abbreviation: Schizophrenia (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40102406 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kaul+I%22">Kaul I</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sawchak+S%22">Sawchak S</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Claxton+A%22">Claxton A</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sauder+C%22">Sauder C</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hassman+HH%22">Hassman HH</searchLink>; CenExel-Hassman Research Institute, Marlton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Kakar+R%22">Kakar R</searchLink>; Segal Trials, Lauderhill, FL, USA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CenExel-Collaborative Neuroscience Research, Los Alamitos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Citrome+L%22">Citrome L</searchLink>; New York Medical College, Valhalla, NY, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+H%22">Zhu H</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Miller+AC%22">Miller AC</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Brannan+SK%22">Brannan SK</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA. sbrannan@karunatx.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918367987006676%22">Schizophrenia (Heidelberg, Germany)</searchLink> [Schizophrenia (Heidelb)] 2025 Mar 18; Vol. 11 (1), pp. 44. <i>Date of Electronic Publication: </i>2025 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+Limited%22">Springer Nature Limited </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9918367987006676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2754-6993 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227546993%22">27546993 </searchLink><i>NLM ISO Abbreviation: </i>Schizophrenia (Heidelb) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40102406 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41537-025-00595-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 44 Titles: – TitleFull: Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kaul I – PersonEntity: Name: NameFull: Sawchak S – PersonEntity: Name: NameFull: Claxton A – PersonEntity: Name: NameFull: Sauder C – PersonEntity: Name: NameFull: Hassman HH – PersonEntity: Name: NameFull: Kakar R – PersonEntity: Name: NameFull: Walling DP – PersonEntity: Name: NameFull: Citrome L – PersonEntity: Name: NameFull: Zhu H – PersonEntity: Name: NameFull: Miller AC – PersonEntity: Name: NameFull: Brannan SK IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 03 Text: 2025 Mar 18 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2754-6993 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Schizophrenia (Heidelberg, Germany) Type: main |
| ResultId | 1 |
